Search
for
Sort by
Research 661–690 of 1000+
- Pathophysiology of Androgenetic Alopecia and Implications for Treatment: An Overview of Current Literature
- Early androgen activity after birth determines the hypothalamic expression of androgen and estrogen receptors in adulthood in female but not in male rats
- Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
- Safety of testosterone treatment in postmenopausal women
- 5alpha-reductase 2 inhibition impairs brain defeminization of male rats: Reproductive aspects
- GG01-19 FINASTERIDE 1 MG: SILENT IMPACTS ON MALE FERTILITY DESPITE PRESERVED HORMONAL BALANCE
- Male Pattern Baldness – Symptoms, Causes, and Treatments
- 5‐Alpha reductase inhibitor related litigation: A legal database review
- Compounded Testosterone Troches TO OPTIMIZE HEALTH AND THE TESTOSTERONE CONTROVERSY.
- The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease
- The human hair: from anatomy to physiology
- 9 Role of 5α-reductase in health and disease
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Current evaluation of amenorrhea
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Transgender Competent Provider
- The Biology of Hair Growth
- Post-finasteride syndrome – does it really exist?
- Chapter 23. Therapeutic Control of Androgen Action
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- Androgen Treatment in Women
- Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients
- The pathophysiology of delayed ejaculation
- Dodatek A: Model matematyczny AL/RC/ASE. Functional Androgen Axis (FOA) - wersja operacyjna v1.2
- Adverse Effects of 5-Alpha-Reductase Inhibitors: a narrative review
- Editor’s picks January 2021
- Androgenetic alopecia; drug safety and therapeutic strategies
- Segmental hair analysis as a retrospective testosterone diary: possibilities and pitfalls
- Testosterone therapy for transgender men
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women